Healthcare provider profile · identity verified

Jeffrey J Eickman, MD

Family Practice · GRAND FORKS, ND · NPI 1578654588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	943	255
Hydrochlorothiazide	Hydrochlorothiazide	349	96
Amlodipine Besylate	Amlodipine Besylate	277	76
Simvastatin	Simvastatin	273	70
Levothyroxine Sodium	Levothyroxine Sodium	262	59
Lisinopril	Lisinopril	262	77
Metoprolol Succinate	Metoprolol Succinate	245	70
Metformin Hcl	Metformin Hcl	238	68
Omeprazole	Omeprazole	231	62
Losartan Potassium	Losartan Potassium	207	58
Pantoprazole Sodium	Pantoprazole Sodium	185	47
Gabapentin	Gabapentin	172	39
Tamsulosin Hcl	Tamsulosin Hcl	158	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	148	36
Metoprolol Tartrate	Metoprolol Tartrate	137	41
Sertraline Hcl	Sertraline Hcl	125	30
Pravastatin Sodium	Pravastatin Sodium	110	28
Allopurinol	Allopurinol	109	25
Clopidogrel	Clopidogrel Bisulfate	104	23
Eliquis	Apixaban	100	19
Furosemide	Furosemide	89	21
Rosuvastatin Calcium	Rosuvastatin Calcium	87	29
Warfarin Sodium	Warfarin Sodium	87	21
Alendronate Sodium	Alendronate Sodium	84	27
Finasteride	Finasteride	81	20
Montelukast Sodium	Montelukast Sodium	79	22
Atenolol	Atenolol	77	19
Fluoxetine Hcl	Fluoxetine Hcl	76	20
Tramadol Hcl	Tramadol Hcl	74	23
Trazodone Hcl	Trazodone Hcl	69	19
Escitalopram Oxalate	Escitalopram Oxalate	67	20
Zolpidem Tartrate	Zolpidem Tartrate	65	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	20
Ropinirole Hcl	Ropinirole Hcl	61	13
Citalopram Hbr	Citalopram Hydrobromide	60	13
Lorazepam	Lorazepam	60	19
Albuterol Sulfate Hfa	Albuterol Sulfate	57	23
Donepezil Hcl	Donepezil Hcl	56	12
Metformin Hcl Er	Metformin Hcl	50	17
Duloxetine Hcl	Duloxetine Hcl	49	11
Ozempic	Semaglutide	43	11
Carvedilol	Carvedilol	42	13
Potassium Chloride	Potassium Chloride	42	13
Amitriptyline Hcl	Amitriptyline Hcl	41	15
Glimepiride	Glimepiride	41	suppressed
Clonazepam	Clonazepam	40	suppressed
Jantoven	Warfarin Sodium	40	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Azithromycin	Azithromycin	38	33
Doxycycline Hyclate	Doxycycline Hyclate	38	30
Propranolol Hcl Er	Propranolol Hcl	38	suppressed
Enalapril Maleate	Enalapril Maleate	37	12
Methylprednisolone	Methylprednisolone	34	30
Bumetanide	Bumetanide	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Spironolactone	Spironolactone	32	11
Benazepril Hcl	Benazepril Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	11
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Prednisone	Prednisone	28	20
Famotidine	Famotidine	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Baclofen	Baclofen	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Amoxicillin	Amoxicillin	18	14
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Cephalexin	Cephalexin	17	15
Ezetimibe	Ezetimibe	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	12
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Tramadol Hcl Er	Tramadol Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Ramipril	Ramipril	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error